NEU 6.41% $15.27 neuren pharmaceuticals limited

Neuren - Cracking the $200m m/cap again., page-97

  1. 466 Posts.
    lightbulb Created with Sketch. 76
    I own a large chunk of NEU shares and have been a holder for a long time now. I've seen a lot of discussion in these HC threads re Lanstead selling their shares. What I don't get is why it is so obvious that they want or need to sell them? Is there no chance that they would also see the medium to long term potential for the share price being multiples of what it is today or have I missed the point entirely?
    Last edited by cableguy1411: 09/09/19
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.